CI Add to watchlist
$268.63 3.97 (-1.46%)
After Hours: $268.63 +0.00 (+0.00%)
Last updated: Apr 15, 2026 21:10
52-Week Range
$268.63
$239.51 $268.63 $350.00

Fundamentals Overview

Cigna Corporation is in the middle of its 52-week range with attractive valuation, trading relatively flat today.

Valuation attractive

P/E 12 PEG 0.16 P/B 1.71 P/S 0.26

Intrinsic value (DCF)

+767.4% upside vs price

Profitability

Net margin 2.2%

Risk (Beta)

0.27 — lower vol

Earnings & growth

EPS $22.40 Rev +3.9% Profit -33.9% vs prior qtr

BullzEye Analysis

Our composite tilts Buy on technicals (e.g. RSI, ADX, trend), fundamentals, sentiment, sector and index context, and risk.

Composite Signal

Sell
Buy
Buy — 72% confidence Risk: Lower Volatility — Beta 0.27. Diversify and only invest what you can afford to lose.

Supporting (Buy):

DCF +767.4% upside vs price · Analyst grade: A- · Sentiment improving (1 upgrade)

Not financial advice. For education and research only; do your own research and consider a financial advisor before investing.

Key Stats

Market Cap
$71.76B
P/E (TTM)
11.99
EPS (TTM)
$22.40
Dividend Yield
2.27%
52-Week Range
$239.51 - $350.00
Volume vs Avg
N/A
Beta
0.27

About

The Cigna Group provides insurance and related products and services in the United States. Its Evernorth segment provides a range of coordinated and point solution health services, including pharmacy, benefits management, care delivery and management, and intelligence solutions to health plans, employers, government organizations, and health care providers. The company's Cigna Healthcare segment offers medical, pharmacy, behavioral health, dental, vision, health advocacy programs, and other prod...
Sector: Healthcare
Headquarters: US
Employees: 71,295
IPO Date: Mar 1982
Beta: 0.27 (Less volatile than market)

Ratings & Grades at a Glance

Overall rating: A-. Recent institutional grades: majority upgrades. Current institutional positions: Buy: 12, Equal Weight: 2, Market Perform: 1, Outperform: 5, Overweight: 10.

Financial story & AI narrative

Open this tab to load the financial story.

Valuation & Ratios

Valuation, liquidity, and profitability metrics are consolidated here (including ratios that previously appeared in the Financials story). Trailing (TTM) vs forward-looking (e.g. DCF) is noted on each line where it matters.

DCF vs price: DCF estimate is $2,330.04; current price is $268.63. That’s a +767.4% gap. When the gap is large (e.g. >20%), that’s divergence; when they’re close, that’s convergence. Differences can reflect growth expectations, sector premiums, or conservative vs. optimistic assumptions. Use DCF as one input alongside technicals and sentiment.

Metric Value
Valuation
P/E (TTM) 11.99
DCF value (model) $2,330.04 (767.4% upside)
PEG (TTM) 0.16
P/B (TTM) 1.71
P/S (TTM) 0.26
P/FCF (TTM) 8.55
Liquidity & enterprise
Current Ratio (TTM) 0.85
Quick Ratio (TTM) 0.72
Cash Ratio (TTM) 0.14
Profitability
ROE (TTM) N/A
ROA (TTM) N/A
Revenue growth (YoY) N/A
Net margin (TTM) 2.17%
Gross margin (TTM) 9.45%
Operating margin (TTM) 3.32%
Debt to equity (TTM) N/A

Latest News

News loads when you open this tab.

Price Target, Ratings & Grades

Analyst price targets, consensus, rating snapshot, and institutional grades for CI.

Analyst Sentiment at a Glance

A- Sentiment Improving
Buy 12Equal Weight 2Market Perform 1Outperform 5Overweight 10
1 upgrade, 0 downgrades
Price Target Consensus
Current $268.63
Median $321.50
Consensus $325.83
Low consensus $300.00
High consensus $375.00

Stock Grades (Institutions)

Institution Action Previous Grade New Grade Date
Bernstein upgrade Market Perform Outperform 2026-03-12
Piper Sandler maintain Overweight Overweight 2026-03-03
Truist Securities maintain Buy Buy 2026-02-17
TD Cowen maintain Buy Buy 2026-02-09
Guggenheim maintain Buy Buy 2026-02-06
Barclays maintain Overweight Overweight 2026-02-06
RBC Capital maintain Outperform Outperform 2026-02-06
Guggenheim maintain Buy Buy 2026-02-02
Barclays maintain Overweight Overweight 2026-01-05
Truist Securities maintain Buy Buy 2026-01-05
Bernstein maintain Market Perform Market Perform 2025-11-12
Wells Fargo maintain Equal Weight Equal Weight 2025-11-05
Goldman Sachs maintain Buy Buy 2025-11-04
JP Morgan maintain Overweight Overweight 2025-11-04
TD Cowen maintain Buy Buy 2025-11-04
Barclays maintain Overweight Overweight 2025-11-03
Barclays maintain Overweight Overweight 2025-09-04
Cantor Fitzgerald maintain Overweight Overweight 2025-08-26
Wells Fargo maintain Equal Weight Equal Weight 2025-08-14
Baird maintain Outperform Outperform 2025-08-14
Guggenheim maintain Buy Buy 2025-08-04
Barclays maintain Overweight Overweight 2025-08-01
RBC Capital maintain Outperform Outperform 2025-06-26
RBC Capital maintain Outperform Outperform 2025-06-03
Barclays maintain Overweight Overweight 2025-06-02
Guggenheim maintain Buy Buy 2025-05-23
Truist Securities maintain Buy Buy 2025-05-12
Guggenheim maintain Buy Buy 2025-05-06
Guggenheim maintain Buy Buy 2025-05-05
Morgan Stanley maintain Overweight Overweight 2025-05-05